Downregulation of β-arrestin 1 suppresses glioblastoma cell malignant progression vis inhibition of Src signaling

Experimental Cell Research

Volumn 357, Issue 1, 2017, Pages 51-58

  Lan, Tian ^a,b   Wang, Haoran ^a   Zhang, Zhihua ^a,b   Zhang, Mingshan ^a   Qu, Yanming ^a   Zhao, Zitong ^b   Fan, Xinyi ^b   Zhan, Qimin ^b   Song, Yongmei ^b   Yu, Chunjiang ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CANCER HOSPITAL   (China)

Author keywords

Cell growth; GBM; Glycolysis; Invasion; Src; arrestin 1

Indexed keywords

BETA ARRESTIN 1; PROTEIN TYROSINE KINASE; TEMOZOLOMIDE; ARRB1 PROTEIN, HUMAN; ARRB1 PROTEIN, MOUSE; DACARBAZINE; PROTEIN KINASE P60;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER MODEL; CANCER SURVIVAL; CELL INVASION; CLINICAL OUTCOME; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; GLIOBLASTOMA; GLYCOLYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT; ANALOGS AND DERIVATIVES; ANIMAL; BRAIN NEOPLASMS; CELL PROLIFERATION; DISEASE COURSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; METABOLISM; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION;

ANIMALS; BETA-ARRESTIN 1; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DACARBAZINE; DISEASE PROGRESSION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; MICE; NEOPLASM INVASIVENESS; PROTO-ONCOGENE PROTEINS PP60(C-SRC); SIGNAL TRANSDUCTION;

EID: 85019365826     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2017.04.023     Document Type: Article

References (40)

1. Van Meir, E.G., Hadjipanayis, C.G., Norden, A.D., Shu, H.K., Wen, P.Y., Olson, J.J., Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J. Clin. 60 (2010), 166–193.
2. Ricard, D., Idbaih, A., Ducray, F., Lahutte, M., Hoang-Xuan, K., Delattre, J.Y., Primary brain tumours in adults. Lancet 379 (2012), 1984–1996.
3. Sanson, M., Idbaih, A., Neuro-oncology: novel molecular targets in treatment of glioblastoma. Nat. Rev. Neurol. 9 (2013), 612–613.
4. Labak, C.M., Wang, P.Y., Arora, R., Guda, M.R., Asuthkar, S., Tsung, A.J., Velpula, K.K., Glucose transport: meeting the metabolic demands of cancer, and applications in glioblastoma treatment. Am. J. Cancer Res. 6 (2016), 1599–1608.
5. Chakravarti, A., Palanichamy, K., Overcoming therapeutic resistance in malignant gliomas: current practices and future directions. Cancer Treat. Res. 139 (2008), 173–189.
6. Luttrell, L.M., Lefkowitz, R.J., The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. J. Cell Sci. 115 (2002), 455–465.
7. Craft, C.M., Whitmore, D.H., The arrestin superfamily: cone arrestins are a fourth family. FEBS Lett. 362 (1995), 247–255.
8. Benovic, J.L., Kuhn, H., Weyand, I., Codina, J., Caron, M.G., Lefkowitz, R.J., Functional desensitization of the isolated beta-adrenergic receptor by the beta-adrenergic receptor kinase: potential role of an analog of the retinal protein arrestin (48-kDa protein). Proc. Natl. Acad. Sci. USA 84 (1987), 8879–8882.
9. Lohse, M.J., Benovic, J.L., Codina, J., Caron, M.G., Lefkowitz, R.J., Beta-arrestin: a protein that regulates beta-adrenergic receptor function. Science 248 (1990), 1547–1550.
10. Krupnick, J.G., Benovic, J.L., The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Annu. Rev. Pharmacol. Toxicol. 38 (1998), 289–319.
11. Kovacs, J.J., Hara, M.R., Davenport, C.L., Kim, J., Lefkowitz, R.J., Arrestin development: emerging roles for beta-arrestins in developmental signaling pathways. Dev. Cell 17 (2009), 443–458.
12. Buchanan, F.G., DuBois, R.N., Emerging roles of beta-arrestins. Cell Cycle 5 (2006), 2060–2063.
13. Lefkowitz, R.J., Rajagopal, K., Whalen, E.J., New roles for beta-arrestins in cell signaling: not just for seven-transmembrane receptors. Mol. Cell 24 (2006), 643–652.
14. Shukla, A.K., Xiao, K., Lefkowitz, R.J., Emerging paradigms of beta-arrestin-dependent seven transmembrane receptor signaling. Trends Biochem. Sci. 36 (2011), 457–469.
15. Hu, S., Wang, D., Wu, J., Jin, J., Wei, W., Sun, W., Involvement of beta-arrestins in cancer progression. Mol. Biol. Rep. 40 (2013), 1065–1071.
16. Sobolesky, P.M., Moussa, O., The role of beta-arrestins in cancer. Prog. Mol. Biol. Transl. Sci. 118 (2013), 395–411.
17. Gurevich, V.V., Gurevich, E.V., Cleghorn, W.M., Arrestins as multi-functional signaling adaptors. Handb. Exp. Pharmacol., 2008, 15–37.
18. Rosano, L., Bagnato, A., beta-arrestin1 at the cross-road of endothelin-1 signaling in cancer. J. Exp. Clin. Cancer Res., 35, 2016, 121.
19. Mandell, J.W., Glass, G., Gianchandani, E.P., Locke, C.N., Amos, S., Bourne, T.D., Schiff, D., Papin, J.A., Dephosphorylation of beta-arrestin 1 in glioblastomas. J. Neuropathol. Exp. Neurol. 68 (2009), 535–541.
20. Yang, Y., Guo, Y., Tan, S., Ke, B., Tao, J., Liu, H., Jiang, J., Chen, J., Chen, G., Wu, B., Beta-arrestin1 enhances hepatocellular carcinogenesis through inflammation-mediated Akt signalling. Nat. Commun., 6, 2015, 7369.
21. Buchanan, F.G., Gorden, D.L., Matta, P., Shi, Q., Matrisian, L.M., DuBois, R.N., Role of beta-arrestin 1 in the metastatic progression of colorectal cancer. Proc. Natl. Acad. Sci. USA 103 (2006), 1492–1497.
22. Qiu, C., Zheng, C., Zhu, L., Qu, X., Shen, H., Du, J., beta-arrestin1 over-expression is associated with an unfavorable prognosis in lung adenocarcinomas and correlated with vascular endothelial growth factor. Int. J. Clin. Exp. Pathol. 8 (2015), 3785–3793.
23. Pillai, S., Trevino, J., Rawal, B., Singh, S., Kovacs, M., Li, X., Schell, M., Haura, E., Bepler, G., Chellappan, S., beta-arrestin-1 mediates nicotine-induced metastasis through E2F1 target genes that modulate epithelial-mesenchymal transition. Cancer Res. 75 (2015), 1009–1020.
24. Nobles, K.N., Guan, Z., Xiao, K., Oas, T.G., Lefkowitz, R.J., The active conformation of beta-arrestin1: direct evidence for the phosphate sensor in the N-domain and conformational differences in the active states of beta-arrestins1 and -2. J. Biol. Chem. 282 (2007), 21370–21381.
25. Luttrell, L.M., Ferguson, S.S., Daaka, Y., Miller, W.E., Maudsley, S., Della Rocca, G.J., Lin, F., Kawakatsu, H., Owada, K., Luttrell, D.K., Caron, M.G., Lefkowitz, R.J., Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. Science 283 (1999), 655–661.
26. Dasgupta, P., Rizwani, W., Pillai, S., Davis, R., Banerjee, S., Hug, K., Lloyd, M., Coppola, D., Haura, E., Chellappan, S.P., ARRB1-mediated regulation of E2F target genes in nicotine-induced growth of lung tumors. J. Natl. Cancer Inst. 103 (2011), 317–333.
27. Li, T.T., Alemayehu, M., Aziziyeh, A.I., Pape, C., Pampillo, M., Postovit, L.M., Mills, G.B., Babwah, A.V., Bhattacharya, M., Beta-arrestin/Ral signaling regulates lysophosphatidic acid-mediated migration and invasion of human breast tumor cells. Mol. Cancer Res. 7 (2009), 1064–1077.
28. Rosano, L., Cianfrocca, R., Masi, S., Spinella, F., Di Castro, V., Biroccio, A., Salvati, E., Nicotra, M.R., Natali, P.G., Bagnato, A., Beta-arrestin links endothelin A receptor to beta-catenin signaling to induce ovarian cancer cell invasion and metastasis. Proc. Natl. Acad. Sci. USA 106 (2009), 2806–2811.
29. Sarkaria, J.N., Kitange, G.J., James, C.D., Plummer, R., Calvert, H., Weller, M., Wick, W., Mechanisms of chemoresistance to alkylating agents in malignant glioma. Clin. Cancer Res. 14 (2008), 2900–2908.
30. Kim, L.C., Song, L., Haura, E.B., Src kinases as therapeutic targets for cancer. Nat. Rev. Clin. Oncol. 6 (2009), 587–595.
31. McCarthy, N., Signalling, SRC and survival. Nat. Rev. Cancer 12 (2012), 80–81.
32. Ahluwalia, M.S., de Groot, J., Liu, W.M., Gladson, C.L., Targeting, SRC in glioblastoma tumors and brain metastases: rationale and preclinical studies. Cancer Lett. 298 (2010), 139–149.
33. Gurevich, V.V., Gurevich, E.V., Arrestins: critical Players in Trafficking of Many GPCRs. Prog. Mol. Biol. Transl. Sci. 132 (2015), 1–14.
34. Zhang, Z., Hao, J., Zhao, Z., Ben, P., Fang, F., Shi, L., Gao, Y., Liu, J., Wen, C., Luo, L., Yin, Z., beta-Arrestins facilitate ubiquitin-dependent degradation of apoptosis signal-regulating kinase 1 (ASK1) and attenuate H2O2-induced apoptosis. Cell Signal. 21 (2009), 1195–1206.
35. Labasque, M., Reiter, E., Becamel, C., Bockaert, J., Marin, P., Physical interaction of calmodulin with the 5-hydroxytryptamine2C receptor C-terminus is essential for G protein-independent, arrestin-dependent receptor signaling. Mol. Biol. Cell 19 (2008), 4640–4650.
36. Dasgupta, P., Rastogi, S., Pillai, S., Ordonez-Ercan, D., Morris, M., Haura, E., Chellappan, S., Nicotine induces cell proliferation by beta-arrestin-mediated activation of Src and Rb-Raf-1 pathways. J. Clin. Investig. 116 (2006), 2208–2217.
37. Buelli, S., Rosano, L., Gagliardini, E., Corna, D., Longaretti, L., Pezzotta, A., Perico, L., Conti, S., Rizzo, P., Novelli, R., Morigi, M., Zoja, C., Remuzzi, G., Bagnato, A., Benigni, A., beta-arrestin-1 drives endothelin-1-mediated podocyte activation and sustains renal injury. J. Am. Soc. Nephrol. 25 (2014), 523–533.
38. Cheung, R., Malik, M., Ravyn, V., Tomkowicz, B., Ptasznik, A., Collman, R.G., An arrestin-dependent multi-kinase signaling complex mediates MIP-1beta/CCL4 signaling and chemotaxis of primary human macrophages. J. Leukoc. Biol. 86 (2009), 833–845.
39. Strungs, E.G., Luttrell, L.M., Arrestin-dependent activation of ERK and Src family kinases. Handb. Exp. Pharmacol. 219 (2014), 225–257.
40. Ryu, J.M., Baek, Y.B., Shin, M.S., Park, J.H., Park, S.H., Lee, J.H., Han, H.J., Sphingosine-1-phosphate-induced Flk-1 transactivation stimulates mouse embryonic stem cell proliferation through S1P1/S1P3-dependent beta-arrestin/c-Src pathways. Stem Cell Res. 12 (2014), 69–85.